Adamas Pharmaceuticals

FDA approves EpiPen rivalAdamis’ epinephrine injection promises to be a lower-cost alterative to EpiPen.
FDA approves new Alzheimer’s drugFDA approved the New Drug Application (NDA) for a new treatment for moderate to severe dementia in Alzheimer’s patients.